Regulatory nod for conducting clinical trials of Colchicine on COVID-19 patients: CSIR
India is one of the largest producers of this key drug and if successful, it will be made available to patients at an affordable cost, IICT Director S Chandrasekhar said. (Representational image)The Drugs Controller General of India (DCGI)…